Our data suggest CD103− CD39+ CD8+ T cells in endometrial cancer are recently activated and likely differentiate towards tissue residence upon exposure to TGF-β, potentially explaining their paucity in the tumor micro-environment. The gene discussed is TGFB1; the disease is endometrial cancer.